Mednet Logo

Would you consider RNI in a patient with axillary recurrence after lumpectomy, whole breast RT and cavity boost 10 years ago?

The patient is now s/p neoadjuvant chemotherapy, mastectomy, and ALND for their ipsilateral recurrence, and pathology showing residual disease (ypT0N2). Would you offer axillary RT in this scenario? Why or why not?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University Hospitals Seidman Cancer Center
Answered on

This patient has residual nodal disease after neoadjuvant chemotherapy and has a high risk of recurrence. I have typically treated the supraclavicular fossa and at risk axilla using a VMAT technique to limit skin dose in the area of overlap. You have 10 years of repair and the patient should tolerat...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC
Answered on

Axillary nodal disease correlates most with chest wall recurrence (60-75% of post mastectomy recurrences are along the chest wall). After a disruption (like multiple surgeries), we don’t exactly know what the recurrence pattern will be, but it is highly unlikely to change to where CW would be a mino...

Join for free or sign in to see the full answer